Hairly is a health-tracking app for iOS that allows users to monitor hair regrowth through photo timelines and treatment logs.
The App DNA
What makes this app unique?
Users hire Hairly to remove the manual friction of tracking hair loss treatments over long periods. The ad-free, organized interface serves as a reliable record for personal or clinical review.
For Individuals experiencing male or female pattern baldness seeking to track treatment efficacy and progress.
What does it look like?
Key features
Upload and tag hair photos by angle for visual comparison.
Log medications and supplements in a centralized dashboard.
B2B portal allowing clinics to access patient progress data.
How much does it cost?
The app operates as a free, ad-free utility, likely serving as a lead-generation tool for the B2B clinic partnership model.
Velocity
Dormant developmentopaqueShow more...
The app has reached a zombie state, with no updates released in over 1,000 days. The development activity has ceased entirely, as the last recorded version was released on November 6, 2023. There is no evidence of ongoing maintenance, feature development, or live operations support.
Who built it?
User Sentiment
What do users think recently?
Fresh user feedback skews thrilled. Users appreciate organizing scattered hair growth photos into a chronological timeline simplifies tracking progress over time and side by side image comparison tools help users visualize changes in specific scalp areas.
How are ratings & reviews evolving?
What users say, by theme
- Organizing scattered hair growth photos into a chronological timeline simplifies tracking progress over time
- Side by side image comparison tools help users visualize changes in specific scalp areas
1 of 1 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for Hairly: Fight Hair Loss
How's the Health & Fitness market?
Hairly occupies a niche in the Health & Fitness category as a specialized tracking utility. Its 5.0-star rating on 15 reviews reflects high satisfaction with the core tracking loop, though the 33-month update gap signals a lack of competitive momentum.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Hairly: Fight Hair Loss
Where is it heading?
The health-tracking market is consolidating around AI-driven insights, making static tracking tools like Hairly increasingly vulnerable to churn. While the B2B clinic integration provides a unique barrier, the lack of feature development means the app will likely lose its consumer-facing relevance unless the promised AI-recommendation engine ships in the next two quarters.
- The 33-month update silence suggests the product is in maintenance mode, which leaves it vulnerable to competitors with active AI-development cadences.
- The B2B clinic integration provides a defensible distribution channel that consumer-only health apps lack, stabilizing the app's long-term utility.
The SWOT
- B2B clinic portal functions as a distribution barrier into professional partnerships
- Ad-free, high-utility tracking interface drives user retention
- Integration of AI-powered growth predictions could capture users seeking automated analysis
Next best moves
Ship AI-powered growth predictions because user demand for automated analysis is rising → capture high-intent users from competitors
+ 1 more prioritized moveThe counter-intuitive read
The 33-month update silence is not just neglect…
Read the full takeSince the last report: The competitive assessment shifted from stable to mixed due to the persistent lack of updates and the rising necessity of AI-driven features to remain relevant.
Bottom line
Hairly provides a high-utility, ad-free tracking experience for pattern baldness, but its 33-month update silence creates a significant churn risk as users migrate to AI-native alternatives, so the PM should prioritize shipping the promised AI-powered analysis to defend the user base.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
Report last updated